3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1
1
Status
Recruiting
4
Terminated
3
Completed
2
Active not recruiting
2
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
5
INDUSTRY
3
NIH
1
NETWORK
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
CNS
3
Conditions
Neoplasms
474
Carcinoma, Non-Small-Cell Lung
449
Breast Neoplasms
331
Neoplasm Metastasis
243
Colorectal Neoplasms
214
Melanoma
213
Leukemia, Myeloid, Acute
191
Multiple Myeloma
180
Recurrence
169
Ovarian Neoplasms
169
Prostatic Neoplasms
163
Lymphoma, Non-Hodgkin
149
Lung Neoplasms
134
Pancreatic Neoplasms
125
Lymphoma
124
Carcinoma, Renal Cell
112
Leukemia, Lymphocytic, Chronic, B-Cell
111
Squamous Cell Carcinoma of Head and Neck
110
Stomach Neoplasms
92
Carcinoma, Hepatocellular
89
Lymphoma, Large B-Cell, Diffuse
88
Leukemia
88
Triple Negative Breast Neoplasms
86
Lymphoma, Follicular
82
Head and Neck Neoplasms
79
Glioblastoma
75
Myelodysplastic Syndromes
70
Urinary Bladder Neoplasms
68
Small Cell Lung Carcinoma
64
Precursor Cell Lymphoblastic Leukemia-Lymphoma
55
Interventions
Transplantation, Homologous
1
Transplantation, Autologous
1
Temozolomide
1
RRx-001
1
Irinotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Terminated
×
INDUSTRY
×
Spinal Cord Neoplasms
×
Clear all
NCT04525014
2024-10-31
PIRATE
EpicentRx, Inc.
Phase 1
Terminated
2 enrolled
NCT02225223
2021-08-11
STARRT
Merit Medical Systems, Inc.
Phase NA
Terminated
35 enrolled
12 charts
NCT00974623
2017-04-05
APPROACH-001
Baxter Healthcare Corporation
Terminated
329 enrolled